

Cover Story
Free
Oregon flirts with—and quickly abandons—plan to deny Medicaid payment for next-generation sequencing
By Matthew Bin Han Ong
The Oregon Health Authority did a considerable amount of work to prepare a plan that would deny Medicaid coverage for next-generation sequencing tests in the state.
In Brief


Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for September
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- How George Tidmarsh crossed the FDA-industry Rubicon
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval - Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA














